INNOVENT BIOLOGICS, INC.

Analyst Reco. Innovent Biologics, Inc.

Equities

1801

KYG4818G1010

Delayed Hong Kong S.E. Other stock markets 01:29:09 2024-05-03 am EDT			5-day change	1st Jan Change
40.5 ^HKD	-3.23%		+11.89%	-5.38%

Apr. 30	Innovent Biologics, Inc. Reports Revenue Results for the First Quarter of 2024	CI
Apr. 30	Innovent Biologics, Inc. Appoints Samuel Zhang as Global Chief Business Officer	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nomura Adjusts Innovent Biologics’ Price Target to HK$55.31 From HK$54.51, Keeps at Buy	Feb. 26	MT
Nomura Adjusts Innovent Biologics’ Price Target to HK$54.51 From HK$45.73, Keeps at Buy	Nov. 06	MT
Nomura Adjusts Innovent Biologics' Price Target to HK$45.73 From SG$54.72, Keeps at Buy	23-07-20	MT
Nomura Adjusts Innovent Biologics' Price Target to HK$54.72 From HK$45.44, Keeps at Buy	23-02-06	MT
Nomura Adjusts Innovent Biologics' Price Target to HK$45.44 From HK$45.38, Keeps at Buy	22-08-26	MT
UBS Adjusts Innovent Biologics' Price Target to HK$42 From HK$39.30, Keeps at Buy	22-08-09	MT
Nomura Adjusts Innovent Biologics' Price Target to HK$45.38 From HK$43.75, Keeps at Buy	22-08-05	MT
Hong Kong stocks down as tech shares slide ahead of Fed rate decision	22-05-04	RE
Nomura Adjusts Innovent Biologics' Price Target to HK$43.75 From HK$49.41, Keeps at Buy	22-04-29	MT
UBS Adjusts Innovent Biologics' Price Target to HK$43 From HK$60, Keeps at Buy	22-04-08	MT
Nomura Adjusts Innovent Biologics' Price Target to HK$49.41 From HK$58.18, Keeps at Buy	22-03-31	MT
Nomura Adjusts Innovent Biologics Price Target to HK$58.18 From HK$92.73, Keeps at Buy	22-02-14	MT
Tech stocks drag Hong Kong shares lower on U.S. rate hike concerns	22-02-11	RE
INNOVENT BIOLOGICS : Nomura Adjusts Innovent's Price Target to HK$113.4 From HK$66.3, Keeps at Buy	21-02-04	MT
Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas	20-12-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer